LifeVantage (L2T1) Stock Overview
Engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
L2T1 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
LifeVantage Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.10 |
| 52 Week High | US$10.40 |
| 52 Week Low | US$3.20 |
| Beta | 0.76 |
| 1 Month Change | -7.27% |
| 3 Month Change | 2.00% |
| 1 Year Change | -42.05% |
| 3 Year Change | -15.70% |
| 5 Year Change | -12.82% |
| Change since IPO | -59.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| L2T1 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 2.4% | -2.5% | -1.5% |
| 1Y | -42.0% | -6.4% | 4.0% |
Return vs Industry: L2T1 underperformed the German Personal Products industry which returned -5.3% over the past year.
Return vs Market: L2T1 underperformed the German Market which returned 4.2% over the past year.
Price Volatility
| L2T1 volatility | |
|---|---|
| L2T1 Average Weekly Movement | 11.3% |
| Personal Products Industry Average Movement | 4.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 12.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: L2T1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: L2T1's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 216 | Terrence Moorehead | www.lifevantage.com |
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name.
LifeVantage Corporation Fundamentals Summary
| L2T1 fundamental statistics | |
|---|---|
| Market cap | €66.66m |
| Earnings (TTM) | €4.37m |
| Revenue (TTM) | €157.46m |
Is L2T1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L2T1 income statement (TTM) | |
|---|---|
| Revenue | US$182.59m |
| Cost of Revenue | US$40.97m |
| Gross Profit | US$141.61m |
| Other Expenses | US$136.54m |
| Earnings | US$5.07m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.40 |
| Gross Margin | 77.56% |
| Net Profit Margin | 2.78% |
| Debt/Equity Ratio | 0% |
How did L2T1 perform over the long term?
See historical performance and comparisonDividends
Does L2T1 pay a reliable dividends?
See L2T1 dividend history and benchmarks| LifeVantage dividend dates | |
|---|---|
| Ex Dividend Date | Sep 01 2026 |
| Dividend Pay Date | Sep 15 2026 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 0 days |
Does L2T1 pay a reliable dividends?
See L2T1 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/14 18:24 |
| End of Day Share Price | 2026/09/11 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2026/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LifeVantage Corporation is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ilya Zubkov | Freedom Broker |
| Mitchell Pinheiro | Imperial Capital |
| Ryan Meyers | Lake Street Capital Markets, LLC |